Key result
CDT wins ~83% patient preference over anticoagulation if it improves exercise capacity without increasing bleeding.
Why the study?
The study was designed to investigate how the outcomes of an RCT comparing catheter-directed thrombolysis versus anticoagulation alone for acute submassive PE would affect clinical decision-making.
How do hypothetical outcomes of catheter-directed thrombolysis versus anticoagulation alone for acute submassive pulmonary embolism affect patient and physician decision-making?
Cross-Sectional
Yes
How do hypothetical outcomes of catheter-directed thrombolysis versus anticoagulation alone for acute submassive pulmonary embolism affect patient and physician decision-making?
Patients are more willing than physicians to accept higher bleeding risks with catheter-directed thrombolysis for submassive pulmonary embolism if it improves long-term exercise capacity.
Answers are grounded in this paper and cite their sources.
Highlights patient-physician discordance in submassive PE preferences; hypothesis-generating for incorporating functional outcomes into CDT trials.
The purpose is to investigate how the outcomes of a randomized controlled trial (RCT) of catheter-directed thrombolysis (CDT) versus anticoagulation alone for acute submassive PE would affect clinical decision-making. An online survey was sent to the Pulmonary Embolism Response Team Consortium members and the North American Thrombosis Forum members. Participants rated their preference for CDT on a 5-point scale in 5 RCT outcome scenarios. In all scenarios, subjects in the CDT group walked farther at 1-year than those in the anticoagulation group. A total of 83.3% of patients and 67.1% of physicians preferred CDT (score > 3) if it improved exercise capacity and did not increase bleeding. In every scenario, patients scored CDT higher than physicians (p < 0.05 for each). Bleeding and clinical deterioration were independently associated with the mean score. Patients’ age, gender, and history of PE did not influence CDT scores (p = 0.083, p = 0.071, p = 0.257 respectively). For patients, 60% > 60 years, 65.5% < 60 years, 57.1% of men, and 66.3% of women preferred CDT across scenarios. In conclusion, the majority of respondents would choose CDT if it improves long-term exercise capacity and does not increase bleeding. Patients appear to accept a higher bleeding risk than physicians if CDT improves long-term exercise capacity.
No takes yet. Share an insight, caveat, or question.
Taslakian et al. (2019) conducted a cross-sectional in Acute submassive pulmonary embolism. Catheter-directed thrombolysis (CDT) vs. Anticoagulation alone was evaluated on Preference for CDT (score > 3 on a 5-point scale) if it improved exercise capacity and did not increase bleeding (p=<0.05). In hypothetical scenarios, 83.3% of patients and 67.1% of physicians preferred catheter-directed thrombolysis over anticoagulation if it improved exercise capacity without increasing bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: